- likes
- 88
Post
“One thing that we need to make sure we do is still maintain control, curiosity, and creativity within our drug designers who’ve been doing these jobs for 30+ years.” At the ETH Board Domain Conference last week, our CTO Sergei Yakneen, explained how Isomorphic Labs has built a comprehensive drug design engine that empowers our scientists to advance programs in ways never before possible. Watch the clip, and if you’d like to join our mission to solve all disease, take a look at our open roles: bit.ly/424SMjZ